Deleted Tweets From Scott Gottlieb, R-D.C.
Scott Gottlieb's accounts: SteveFDA
Tracked Between: October 20, 2017-January 20, 2021
SteveFDA (R-D.C.)
@SGottliebFDA
To inform our policymaking, #FDA advances a new survey of health professionals to gauge how promotional activities by drug makers influence provider perceptions related to abuse-deterrent formulations for opioid products. https://t.co/R9PHu52FLe
SteveFDA (R-D.C.)
@SGottliebFDA
RT @FrankYiannasFDA: Industry can do much to advance food safety. Government can do a lot too. What’s clear to me, having been on both… https://t.co/BuIJujytun
SteveFDA (R-D.C.)
@SGottliebFDA
RT @FDATobacco: It’s Brain Awareness Week! � During #BrainWeek discover some facts about smoking and the brain. #FACT Smoking ca… https://t.co/pKNlfJ4d9O
SteveFDA (R-D.C.)
@SGottliebFDA
RT @US_FDA: Smoking can block blood flow to the brain and can lead to stroke which can cause brain damage and death. During… https://t.co/P9OL5U9QkU
SteveFDA (R-D.C.)
@SGottliebFDA
RT @LGMAnews: .@US_FDA Commissioner Scott Gottlieb, M.D. and Deputy Commissioner @FrankYiannasFDA, emphasized the need for additi… https://t.co/yYZZU1Fm4T
SteveFDA (R-D.C.)
@SGottliebFDA
We’ve posted the agenda for our March 25-26 meeting on breast implants. We look forward to thoughtful engagement with patients, scientists, doctors and manufacturers about breast implants and the growing science regarding their risks along with benefits. https://t.co/2y8ro8G1fw https://t.co/lnD1gGQDUQ
SteveFDA (R-D.C.)
@SGottliebFDA
Today, #FDA requested new funding in the President’s FY2020 budget to continue to advance robust reg. framework for e-cigarettes oversight, prevent youth access/initiation & harness innovation to advance safety of food, compounded drugs, U.S. blood supply https://t.co/KCBAcrmYxr
SteveFDA (R-D.C.)
@SGottliebFDA
We’re grateful for the Administration’s support of #FDA’s initiatives for urgent public health priorities and believe these investments in our core consumer protection mission will ultimately lead both to better health outcomes for American families and to a more vibrant economy
SteveFDA (R-D.C.)
@SGottliebFDA
RT @FDAPatientinfo: Attending the Patient Advocacy Summit today in Philadelphia? Our Director, Andrea Furia-Helms, will be discussing… https://t.co/QCzk3JXxUQ
SteveFDA (R-D.C.)
@SGottliebFDA
RT @FDAOMH: Vaccines are safe, effective and one of our greatest public health achievements. Get the facts on vaccines at the M… https://t.co/twSopXiZ2F
SteveFDA (R-D.C.)
@SGottliebFDA
RT @FDASpox: Statement from @SGottliebFDA on request for new #FDA funding to continue to advance a robust reg. framework for ove… https://t.co/C84YwG94p2
SteveFDA (R-D.C.)
@SGottliebFDA
These substantial new resources in the @POTUS Budget will help #FDA continue to exert aggressive oversight to stop youth use of e-cigs, while implementing an appropriate regulatory framework to oversee the adult use of these products. https://t.co/8TVV2NPL1B
SteveFDA (R-D.C.)
@SGottliebFDA
I’m delighted by the announcement from @SecAzar that @NCIDirector will serve as acting commissioner of #FDA. Ned is a friend to FDA, a great public health champion, a dedicated physician, and will be warmly welcomed into his new role. FDA will benefit greatly from his leadership.
SteveFDA (R-D.C.)
@SGottliebFDA
RT @SeanKhozin: The spirit of #innovation and collaboration that has been one of the defining features of @NCIDirector’s tenure to date wil… QT @SGottliebFDA: I’m delighted by the announcement from @SecAzar that @NCIDirector will serve as acting commissioner of #FDA. Ned is… https://t.co/5sjMIbyeT1)
SteveFDA (R-D.C.)
@SGottliebFDA
RT @FDA_Drug_Info: #FDA releases four draft guidances and one final guidance to encourage broadening of patient participation in cance… https://t.co/W2CP1JkKGD
SteveFDA (R-D.C.)
@SGottliebFDA
RT @tmprowell: Four new draft Guidances & one final Guidance from #FDAOncology on eligibility criteria for #oncology… https://t.co/irLQXVhUhg
SteveFDA (R-D.C.)
@SGottliebFDA
RT @FDASpox: Today, @US_FDA qualified a biomarker medical device development tool. The tool provides a standard way for doctors… https://t.co/BgTq0RhDhw
SteveFDA (R-D.C.)
@SGottliebFDA
We hope today’s approval of a new generic will help reduce the valsartan shortage, and we remain committed to implementing measures to prevent the formation of impurities during drug manufacturing processes for existing and future valsartan products. https://t.co/uh4NcpjX3p
SteveFDA (R-D.C.)
@SGottliebFDA
RT @FDASpox: Read @SGottliebFDA’s statement on advancing new policies aimed at preventing youth access to, and appeal of, flavor… https://t.co/iSisP3japa
SteveFDA (R-D.C.)
@SGottliebFDA
RT @SGottliebFDA: The #FDA will not allow a generation of children to become addicted to nicotine. This effort will carry on. This is… https://t.co/Nrlko72P6l